Zollinger‑Ellison-like hypergastrinemia - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Zollinger‑Ellison‑like Hypergastrinemia: A Complete Patient Guide

Zollinger‑Ellison‑like Hypergastrinemia: A Complete Patient Guide

Overview

Hypergastrinemia refers to an abnormally high level of the hormone gastrin in the blood. Zollinger‑Ellison‑like hypergastrinemia describes the pattern of gastrin excess that resembles that seen in Zollinger‑Ellison syndrome (ZES) but occurs without a confirmed gastrinoma (a gastrin‑producing tumor). This condition can be caused by chronic stimulation of gastrin production, certain medications, or other gastrointestinal disorders.

Typical patients are adults between 30 and 70 years old, with a slight male predominance (≈55 %). The exact prevalence is unclear because many cases are identified only after testing for other conditions, but studies estimate that 0.5–1 % of patients undergoing evaluation for unexplained peptic ulcer disease have elevated gastrin levels without a tumor.1

Symptoms

Because gastrin stimulates gastric acid secretion, the clinical picture is dominated by acid‑related complaints. The following list includes the most common and less‑common manifestations:

Digestive symptoms

  • Abdominal pain – usually epigastric, burning, worsens after meals.
  • Recurrent or refractory peptic ulcers – ulcers that fail to heal despite standard therapy.
  • Heartburn & gastro‑esophageal reflux disease (GERD) – persistent acid reflux.
  • Diarrhea – chronic watery stools caused by acid inactivation of pancreatic enzymes.
  • Nausea & vomiting – especially after a large meal.
  • Loss of appetite – due to discomfort after eating.

Systemic symptoms

  • Weight loss – from malabsorption and reduced intake.
  • Fatigue – secondary to anemia or nutrient deficiencies.
  • Iron‑deficiency anemia – chronic bleeding from ulcers.
  • Osteoporosis – long‑term acid excess can impair calcium absorption.

Rare/Advanced signs

  • Upper gastrointestinal (GI) bleeding – melena or hematemesis.
  • Perforated ulcer – sudden severe abdominal pain, rigid abdomen.
  • Pancreatic enzyme deficiency – steatorrhea (fatty stools) in long‑standing cases.

Causes and Risk Factors

In “Zollinger‑Ellison‑like” hypergastrinemia, elevated gastrin is not driven by a true gastrinoma. The most frequent contributors are:

Medication‑related causes

  • Proton‑pump inhibitors (PPIs) – long‑term use removes the acid feedback inhibition, prompting gastrin rise (often 2‑5 × normal).
  • Histamine‑2 receptor antagonists (H2 blockers) – similar mechanism, though usually milder.

Physiologic or disease‑related stimulators

  • Chronic atrophic gastritis – loss of parietal cells reduces acid, leading to compensatory gastrin rise.
  • Helicobacter pylori infection – especially in the antrum, increases gastrin release.
  • Secretin‑resistant hyperchlorhydria – rare inherited condition.
  • Renal failure – decreased clearance of gastrin.
  • Gastric outlet obstruction – retained food stimulates gastrin.

Risk factors

  • Long‑term PPI therapy (>1 year) without a clear indication.
  • History of H. pylori infection or chronic gastritis.
  • Chronic kidney disease (stage 3 or higher).
  • Family history of endocrine tumors (MEN‑1 syndrome).
  • Age > 50 years – gastric mucosal changes become more common.

Diagnosis

Diagnosing Zollinger‑Ellison‑like hypergastrinemia is a stepwise process that rules out true ZES while identifying underlying triggers.

1. Clinical assessment

  • Detailed history of acid‑related symptoms, medication use, and prior ulcer disease.
  • Physical exam focusing on abdominal tenderness and signs of anemia.

2. Laboratory tests

  • Serum gastrin level – fasting sample; values > 100 pg/mL are abnormal, but levels > 1,000 pg/mL raise suspicion for gastrinoma.
  • Gastric pH – measured via nasogastric aspirate; a pH < 2 supports acid hypersecretion.
  • Complete blood count (CBC) – looks for anemia.
  • Serum calcium & parathyroid hormone – to screen for MEN‑1.
  • Renal function panel – creatinine, eGFR.

3. Imaging & functional studies (to exclude gastrinoma)

  • Somatostatin receptor scintigraphy (Octreoscan) or 68Ga‑DOTATATE PET/CT – highly sensitive for neuroendocrine tumors.
  • Endoscopic ultrasound (EUS) – visualizes pancreatic/duodenal lesions as small as 5 mm.
  • CT or MRI abdomen – cross‑sectional imaging for larger tumors.

4. Exclusion of H. pylori and other causes

  • Urea breath test, stool antigen, or gastric biopsy.
  • Histology from upper endoscopy if ulcer disease is present.

If imaging and functional studies are negative, gastrin remains elevated, and a reversible cause (e.g., PPI use) is identified, the diagnosis is “Zollinger‑Ellison‑like hypergastrinemia.”2

Treatment Options

Treatment aims to reduce gastric acid output, address the underlying cause, and heal ulcer disease.

1. Medication

  • Proton‑pump inhibitors (PPIs) – high‑dose (e.g., omeprazole 40–80 mg/day) are first‑line for acid control. In this specific condition, PPIs are used after a careful taper if they were the cause of hypergastrinemia.
  • Histamine‑2 receptor antagonists (H2 blockers) – useful for mild cases or as adjuncts.
  • Somatostatin analogues (octreotide, lanreotide) – can lower gastrin secretion when medication‑induced hypergastrinemia persists after PPI withdrawal.
  • Antibiotic eradication therapy for H. pylori – triple therapy (clarithromycin‑based) or bismuth quadruple therapy.
  • Supplementation – iron, calcium, vitamin D, and B12 if deficiencies develop.

2. Addressing the precipitating factor

  • Gradual taper and discontinuation of PPIs if they are deemed the primary driver.
  • Switch to intermittent H2‑blocker use or antacids for symptom control.
  • Management of chronic kidney disease (dialysis, nephrology referral).

3. Endoscopic and surgical interventions

  • Endoscopic therapy – coagulation or clipping of bleeding ulcers.
  • Surgical resection – reserved for patients in whom a hidden gastrinoma is later discovered or for refractory ulcer disease unresponsive to medical therapy.

4. Lifestyle modifications

  • Eat small, frequent meals; avoid late‑night eating.
  • Limit irritants: caffeine, alcohol, nicotine, and very spicy foods.
  • Maintain adequate hydration; consider a low‑fat diet if steatorrhea occurs.

Living with Zollinger‑Ellison‑like Hypergastrinemia

Successful long‑term management combines medication adherence, regular monitoring, and lifestyle choices.

Daily management tips

  • Take acid‑suppressing medication exactly as prescribed. Do not skip doses, even if you feel better.
  • Keep a symptom diary. Note pain patterns, bowel movements, and any triggers.
  • Schedule regular follow‑up labs. Fasting gastrin, CBC, and iron studies every 6–12 months.
  • Maintain a balanced diet. Include calcium‑rich foods (dairy, fortified plant milks) and vitamin D sources.
  • Avoid NSAIDs and aspirin unless directed by a physician, as they worsen ulcer risk.
  • Stay active. Moderate exercise supports bone health and gastrointestinal motility.
  • Educate family and close contacts about your condition and the signs that warrant urgent care.

Monitoring for complications

Visit your gastroenterologist if you notice new‑onset dysphagia, unexplained weight loss > 10 lb, or persistent diarrhea despite treatment. Annual endoscopy may be recommended for patients with a history of refractory ulcers.3

Prevention

While you cannot completely prevent a hormonally driven condition, you can reduce the risk of developing hypergastrinemia or worsening an existing state.

  • Use PPIs only when clearly indicated and for the shortest effective duration.
  • Screen and eradicate H. pylori before starting long‑term acid suppression.
  • Manage chronic diseases such as kidney disease and autoimmune gastritis with specialist care.
  • Limit alcohol, tobacco, and caffeine which can increase acid secretion.
  • Adopt a diet rich in fiber and low in processed fats to support overall GI health.

Complications

If left untreated, the excess acid and gastrin can lead to serious health problems.

  • Refractory or recurrent peptic ulcers – may bleed or perforate.
  • Upper GI bleeding – melena, hematemesis, anemia.
  • Perforated ulcer – medical emergency with peritonitis.
  • Gastro‑esophageal reflux disease complications – Barrett’s esophagus, strictures.
  • Nutrient malabsorption – iron, calcium, vitamin B12 deficiencies.
  • Osteoporosis/osteopenia – due to chronic calcium loss.
  • Pancreatic enzyme inactivation – leading to steatorrhea and weight loss.
  • Potential progression to true gastrinoma – rare, but surveillance is recommended in high‑risk patients (e.g., MEN‑1 carriers).

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Profuse vomiting that contains blood or looks like coffee grounds.
  • Black, tarry stools (melena) or bright red blood per rectum.
  • Sudden, severe abdominal pain that does not improve with rest or medication.
  • Fever > 101 °F (38.5 °C) with abdominal pain (possible perforation or infection).
  • Sudden fainting, dizziness, or rapid heartbeat accompanied by abdominal pain.
  • Unexplained weight loss > 10 % of body weight within a few months.

These signs may indicate ulcer bleeding, perforation, or another life‑threatening complication that requires immediate treatment.

For all other concerns, schedule an appointment with your gastroenterologist or primary‑care provider. Early detection and appropriate management dramatically improve quality of life and reduce the risk of serious complications.

References:

  1. Mayo Clinic. “Hypergastrinemia.” Accessed April 2024. https://www.mayoclinic.org
  2. CDC. “Helicobacter pylori and Gastric Cancer.” Updated 2023. https://www.cdc.gov
  3. Cleveland Clinic. “Management of Refractory Peptic Ulcer Disease.” 2022. https://my.clevelandclinic.org
  4. National Institutes of Health. “Guidelines for the Diagnosis and Management of Zollinger‑Ellison Syndrome.” 2021.
  5. World Health Organization. “Classification of Digestive System Tumours.” 2020.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References